£55.53

MDPI AG Roles of NF-ΚB in Cancer and Their Therapeutic Approaches

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£56 today · all-time low £54 (May 2026) · usually £56

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days · 91 data points

Historical
Generating forecast…
£55.58 £54.17 £54.48 £54.79 £55.09 £55.40 £55.71 21 May 2026 12 June 2026 05 July 2026 27 July 2026 19 August 2026

Price Distribution

Price distribution over 91 days • 2 price levels

Days at Price
Current Price
21 days 70 days · current 0 18 35 53 70 £54 £56 Days at Price

Price Analysis

Most common price: £56 (70 days, 76.9%)

Price range: £54 - £56

Price levels: 2 different prices over 91 days

Description

Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broadly-active anticancer drugs have a small therapeutic index and barely discriminate between malignant and normal cells. In recent years the focus has shifted to the development of rationally designed, molecularly-targeted therapy for the treatment of a specific cancer, therefore offering the promise of greater specificity coupled with reduced systemic toxicity. NF-kB transcription factor family as emerged as such a promising target for cancer therapy. This Special Issue will explore the routes from NF-kB basic research, cancer research and oncogenomics into the development of NF-kB-based cancer therapeutics and biomarkers. We invite research and review papers in any area of the NF-kB field that are related, but not limited to, fundamental understanding of NF-kB signaling pathways, gene expression profiling, epigenetic regulation, diagnostic, prognostic and pharmacogenomic biomarkers, molecular targets driving the progression of human cancers, cancer drug development on these targets, clinical trial with new agents, and validation in animal models. We hope that this Special Issue reflects the exciting era that we are living in with respect to the field of NF-kB and its applications in cancer research.

Product Specifications

Brand
MDPI AG
Format
paperback
Domain
Amazon UK
Release Date
23 July 2018
Listed Since
25 July 2018

Barcode

No barcode data available

Similar Products You Might Like

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
80% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 08 Aug 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
79% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 06 Aug 2026
Cell Signaling & Molecular Targets in Cancer
79% match

Cell Signaling & Molecular Targets in Cancer

Springer

£108.00 01 Aug 2026
Pharmaceutical Perspectives of Cancer Therapeutics
79% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 08 Aug 2026
Protein Kinase C: Emerging Roles and Therapeutic Potential (Biochemistry Research Trends)
79% match

Protein Kinase C: Emerging Roles and Therapeutic Potential (Biochemistry Research Trends)

£73.86 06 Aug 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
78% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£76.42 05 Aug 2026
Nutraceuticals and Cancer
78% match

Nutraceuticals and Cancer

Springer

£113.76 05 Aug 2026
Gene Regulation and Therapeutics for Cancer
78% match

Gene Regulation and Therapeutics for Cancer

CRC Press

£72.24 04 Aug 2026
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
78% match

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Elsevier

£135.56 05 Aug 2026
78% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Elsevier

£153.99 05 Aug 2026
Bioactive Essential Oils and Cancer
78% match

Bioactive Essential Oils and Cancer

Springer

£108.01 04 Aug 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
78% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.67 05 Aug 2026
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
77% match

New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)

Springer

£77.88 06 Aug 2026
Cancer Metabolism: Molecular Mechanisms and Therapeutic Strategies (Cancer Treatment and Research, 195)
77% match

Cancer Metabolism: Molecular Mechanisms and Therapeutic Strategies (Cancer Treatment and Research, 195)

Springer

£88.17 02 Jul 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
77% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£108.01 06 Aug 2026
Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices
77% match

Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices

Elsevier

£119.82 08 Aug 2026
Pathobiology of Cancer Regimen-Related Toxicities
77% match

Pathobiology of Cancer Regimen-Related Toxicities

Springer

£108.01 06 Aug 2026
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
77% match

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

Springer

£100.11 06 Aug 2026
Systems Biology in Cancer Research and Drug Discovery
77% match

Systems Biology in Cancer Research and Drug Discovery

Springer

£108.01 05 Aug 2026
Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs
77% match

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Springer

£77.90 04 Aug 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
77% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£108.01 08 Aug 2026
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
77% match

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£108.01 05 Aug 2026
Drug Discovery in Pancreatic Cancer: Models and Techniques
77% match

Drug Discovery in Pancreatic Cancer: Models and Techniques

Springer

£108.01 06 Aug 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
76% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£166.02 07 Aug 2026